SHARE: +/-: -0.14 SEK / Bid: 6.62 SEK / Ask: 6.74 SEK / Price: 6.62 SEK / High: 6.82 SEK / Low: 6.54 SEK / Quantity: 23 961 / Turnover: 158 940 SEK / 2020-09-29 09:22 (CEST)
 

Business Development

Spago Nanomedical focuses on the development of novel nanomedical tumor selective products for cancer diagnostics and therapy.

We welcome a dialogue with potential partners regarding cooperation and out-licensing of the company’s projects and technologies.

For more information regarding business development, please contact CEO Mats Hansen at mats.hansen@spagonanomedical.se